NEW YORK (GenomeWeb News) – Horizon Discovery said today it has entered into a research collaboration covering gene editing with the Institute of Neurology, University College London.

The partnership will focus on creating human isogenic disease model cell lines with the insertion of Huntington disease-causing triplet repeats. The program at UCL is a new disease area for Horizon, and inserting triplet repeats into a wild type genome is a new alteration application for the company's rAAV-mediated human gene-editing platform called Genesis, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.